Abstract-Effects of 4-aminomethyl-1 -benzylpyrrolidin-2-one-hemifumarate (WEB 1881 FU), a novel pyrrolidinone nootropic, on acetylcholine (ACh) receptors and adrenoceptors were investigated using crude membranes of the rat brain. The affinity order of WEB 1881 FU was: M,-muscarinic (m) ACh receptor>M2-mACh receptor>a2-adrenoceptor>(3-adrenoceptor>a, -adrenoceptor>nicotinic ACh re ceptor.
The WEB 1881 FU-competition curve for [3H]pirenzepine binding in hippocampal membranes was rightward-shifted by GTPrS; such behavior was also observed in the case of oxotremorine but not with scopolamine.
The effects of long-term administration of WEB 1881 FU (30 mg/kg/day, i.p.) for 21 days resulted in a significant decrease in the Bmax of [3H]quinuclidinyl benzilate binding in the cerebral cortex, hippocampus and striatum.
In addition, the B,,,,,, of [3 H]pirenzepine binding to hippocampal and striatal membranes and that of [3H]AF-DX 116 binding to cerebellar membranes were significantly decreased as well. From these results, WEB 1881 FU seems to act on M, -mACh receptors, and its long-term administration probably induces the down-regulation of mACh receptors, mainly M,-mACh receptors in the hippocampus and striatum and M2-mACh receptors in the cerebellum.
Recent investigations
have demonstrated cholinergic dysfunctions in the cerebral cortex and hippocampus of patients with Alzheimer's disease (AD) and semile dementia of the Alzheimer's type (SDAT). The block of central muscarinic acetylcholine (mACh) receptors by scopolamine results in similar loss of memory and cognition to that in patients with AD and/or SDAT (1, 2). Scopolamine also caused the dysfunctions of learning and memory in mice (1 ). In addition, the nor adrenergic system has an important role in learning and memory (3, 4), and a,-, a2 and (3-adrenoceptors are also changed in the CNS of AD (2).
WEB 1881 FU, 4-aminomethyl-1 -benzyl pyrrolidin-2-one-hemifumarate, has been de veloped as a novel nootropic drug (5). Two pharmacological studies have showed that the drug ameliorates the impairment of work ing memory induced by scopolamine and that by cerebral ischemia in rats (6) and facilitates the muscarinic transmission via action on presynaptic muscarinic receptors in dogs (7). However, the nootropic action of WEB 1881 FU has not been characterized in detail, and the following remain to be elucidated: 1 ) which type of acetylcholine (ACh) receptors and adrenoceptors, and 2) which subtypes of muscarinic ACh (mACh) receptors are re sponsible for its action in the brain. In ad dition, it is important to cletermine the in fluences of chronic administration of the nootropic to determine the toxicology of this agent in clinical pharmacology. The repeated administration of WEB 1881 FU for 7 and 21 days did not cause behavioral change in rats. We also examined the effects of repeated ad ministration of this drug on ACh receptors and adrenoceptors in different brain regions. (Hy), 5) midbrain (MB), 6) medulla oblongata (MO) and 7) cerebellum (Cr) were homogenized with 10 volumes of 50 mM Tris-HCI buffer (pH 7.4), and these homogenates were centrifuged at 50,000 X g for 20 min. The pellets thus obtained were washed three times with the same buffer. The sedimented membranes were suspended (5 10 mg/ml) in 50 mM Tris-HCI buffer (pH 7.4) and stored at -80°C.
Receptor binding assay: The total volume of the reaction mixture was 100 ;d, and it con tained 100 mM NaCI, 25 mM MgCl2 in 50 mM Tris-HCI buffer (pH 7. Data analysis: The data from the receptor binding assay were subjected to Scatchard analysis (11) to determine the dissociation constant (KD) and the number of the binding sites (Borax). The displacement curves of WEB 1881 FU were computer-analyzed with a one site or two-site model using the modified LIGAND program (12) by a nonlinear least squares curve-fitting procedure, the simplex method (13 The equilibrium binding of each radiolabeled ligand in the membranes of rat whole brains were performed by the procedure described under "Materials and Methods". These data were analyzed by the method of Scatchard (11) and the values of KD and Bmax were determined. QNB, quinuclidinyl henzilate; ICYP, iodocyanopindolol; n, the number of experiments. (Fig. 2); i.e., the Hill coefficients (nH) were significantly lower than unity (Table 3) .
GTPrS at 20 ,uM did not shift the competition of the antagonist scopolamine, but clearly affected the competition of the agonist oxotremorine (Fig. 2) . In contrast, GTPrS partially induced a rightward-shift in the WEB 1881 FU competition curve for [3H]pirenze pine binding. The competition curves of oxotremorine and WEB 1881 FU in the pre sence of 20 ,uM GTPrS and the curve of scopolamine in the presence or absence of GTPrS were steep, showing that nH is close to unity (Table 3 ). In addition, the Ki values of oxotremorine and WEB 1881 FU in the presence of GTPrS were significantly (P< 0.05) increased as compared to those in the control (Table 3) . Therefore, the competition curves of WEB 1881 FU and oxotremorine were computer-analyzed with the two-site Table 3 ) and a two-site model (shown in Table 6 Table 1 ). nH, puseudo Hill coefficient. (Fig. 3, A and C) . Ca hopantenate-treatment decreased the [3H]rauwolscine binding in the hypothalamus and midbrain and increased it in the cerebellum (Fig. 3D). [1251] ICYP binding in the hypothalamus was increased by the repeated administration of WEB 1881 FU (Fig. 3E) .
Effects without changing the K" values ( (Table 6 ).
Discussion
The results presented here suggest that WEB 1881 FU could directly bind to brain receptors with the following potency order: Mt-mACh receptor > M2-mACh receptor > a2-adrenoceptor > /3-adrenoceptor > a, -ad renoceptor > nACh receptor. Recently, Haga et al. reported that mACh receptor agonists have the GTP-effect in a reconstitution ex periment using purified Mi -mACh receptors and GTP-binding protein (G; and Go) (14) . To clarify whether WEB 1881 FU acts as an agonist or an antagonist on M, -mACh re ceptors, we examined the effects of GTPrS. GTPrS did not induce the shift of the scopol amine-competition curve for [3H]pirenzepine binding to hippocampal membranes, but induced the rightward-shift of the oxo tremorine-competition curve (Fig. 2) . The WEB 1881 FU-competition curve for [3H] pirenzepine binding was also rightward shifted by GTPrS, like that for oxotremorine, although the extent for WEB 1881 FU was less than that for oxotremorine.
Therefore, WEB 1881 FU may be regarded as a partial agonist of M1-mACh receptors in the CNS. However, it will be interesting to determine if WEB 1881 FU has an intrinsic efficacy as a partial agonist of M1-mACh receptors in the brain. Scopolamine, a mACh receptor antagonist, is known to induce the impairment of learning and memory (1), while oxotremorine, a mACh receptor agonist, reverses the scopolamine and fornix damage-induced impairment of learning and memory (15, 16 (20) . WEB 1881 FU, however, directly binds to M1-mACh receptors with high affinity, with a KD of approximately 6 /iM. Ca hopantenate contains r-aminobutyric acid (GABA) and pantoyl moietis in its chemical and has improving effects on cholinergic function in the CNS (21-23). The drug seems to be an agonist for GABAA receptors, since the increase of ACh release from brain slices evoked by Ca hopantenate is antagonized by bicuculline (21) . In addi tion, Ca hopantenate could not bind to M, mACh receptors in rat brain membranes (Fig.  1) . Thus, the interaction of Ca hopantenate with GABA receptors is related to its phar macological action as an antidementia drug (21) . WEB 1881 FU is another pyrrolidinone derivative, like a aniracetam with antidementia action, but may also have a partial M1-mACh agonistic effect compared to aniracetam.
In conclusion, WEB 1881 FU exerts its antidementia action by a different mechanism from Ca hopantenate and has different effects than aniracetam. WEB 1881 FU is probably effective on dementia due to the dysfunction of the cholinergic system in the CNS.
